BACKGROUND AND OBJECTIVES: Vascular calcification is a major contributor to morbidity and mortality in hemodialysis. The objective of this pilot study was to determine the feasibility, safety and efficacy of sodium thiosulfate (STS) in the progression of vascular calcification in hemodialysis patients. METHODS: Chronic hemodialysis patients underwent a battery of cardiovascular tests. Those with coronary artery calcium (Agatston scores >50) received intravenous STS after each dialysis for 5 months (n = 22) and the tests were repeated. Changes in MDCT-determined calcification were assessed as the mean annualized rate of change in 3 vascular beds (coronary, thoracic and carotid arteries) and in L1-L2 vertebral bone density. RESULTS: Although individual analyses showed coronary artery calcification progression in 14/22 subjects, there was no progression in the mean annualized rate of change of vascular calcification in the entire group. The L1-L2 vertebral bone density showed no changes. There were no correlations between rates of progression of vascular calcification and phosphorus, fetuin or C-reactive protein levels. Changes in coronary artery calcification scores correlated with those of the thoracic aorta. CONCLUSION: STS treatment is feasible, appears safe and may decrease the rate of progression of vascular calcification in hemodialysis patients. A large, randomized, controlled trial is warranted.
BACKGROUND AND OBJECTIVES:Vascular calcification is a major contributor to morbidity and mortality in hemodialysis. The objective of this pilot study was to determine the feasibility, safety and efficacy of sodium thiosulfate (STS) in the progression of vascular calcification in hemodialysis patients. METHODS: Chronic hemodialysis patients underwent a battery of cardiovascular tests. Those with coronary artery calcium (Agatston scores >50) received intravenous STS after each dialysis for 5 months (n = 22) and the tests were repeated. Changes in MDCT-determined calcification were assessed as the mean annualized rate of change in 3 vascular beds (coronary, thoracic and carotid arteries) and in L1-L2 vertebral bone density. RESULTS: Although individual analyses showed coronary artery calcification progression in 14/22 subjects, there was no progression in the mean annualized rate of change of vascular calcification in the entire group. The L1-L2 vertebral bone density showed no changes. There were no correlations between rates of progression of vascular calcification and phosphorus, fetuin or C-reactive protein levels. Changes in coronary artery calcification scores correlated with those of the thoracic aorta. CONCLUSION:STS treatment is feasible, appears safe and may decrease the rate of progression of vascular calcification in hemodialysis patients. A large, randomized, controlled trial is warranted.
Authors: Sharon M Moe; Kalisha D O'Neill; Martina Reslerova; Martina Resterova; Naomi Fineberg; Scott Persohn; Cristopher A Meyer Journal: Nephrol Dial Transplant Date: 2004-07-13 Impact factor: 5.992
Authors: John E Hokanson; Todd MacKenzie; Gregory Kinney; Janet K Snell-Bergeon; Dana Dabelea; James Ehrlich; Robert H Eckel; Marian Rewers Journal: AJR Am J Roentgenol Date: 2004-05 Impact factor: 3.959
Authors: Sumeet Subherwal; Lisa de las Fuentes; Alan D Waggoner; Sharon Heuerman; Karen E Spence; Victor G Davila-Roman Journal: Am Heart J Date: 2010-06 Impact factor: 4.749
Authors: W G Goodman; J Goldin; B D Kuizon; C Yoon; B Gales; D Sider; Y Wang; J Chung; A Emerick; L Greaser; R M Elashoff; I B Salusky Journal: N Engl J Med Date: 2000-05-18 Impact factor: 91.245
Authors: J T Papadakis; A Patrikarea; G E Digenis; K Stamatelou; I Ntaountaki; V Athanasopoulos; N Tamvakis Journal: Nephron Date: 1996 Impact factor: 2.847
Authors: Stephan Achenbach; Dieter Ropers; Karsten Pohle; Alexander Leber; Christian Thilo; Andreas Knez; Theresa Menendez; Ralph Maeffert; Magda Kusus; Matthias Regenfus; Andrea Bickel; Ralph Haberl; Gerhard Steinbeck; Werner Moshage; Werner G Daniel Journal: Circulation Date: 2002-08-27 Impact factor: 29.690
Authors: Alan A Sag; Adrian Covic; Gerard London; Marc Vervloet; David Goldsmith; Jose Luis Gorriz; Mehmet Kanbay Journal: Int Urol Nephrol Date: 2016-02-22 Impact factor: 2.370
Authors: Michael E Seifert; Lisa de las Fuentes; Marcos Rothstein; Dennis J Dietzen; Andrew J Bierhals; Steven C Cheng; Will Ross; David Windus; Víctor G Dávila-Román; Keith A Hruska Journal: Am J Nephrol Date: 2013-08-07 Impact factor: 3.754